Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
Sijoittajakalenteri ei ole saatavilla | ||
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
2.6. · MuokattuD. Boral ARC / Exascale Labs (future XLAB). I went through the 852-page S-4 (filed 2026-05-14), AI-assisted, and checked the sponsor's track record. Verdict: uninvestable. A going-concern AI-compute startup with $7M of revenue is being floated at a $500M pre-money / ~$632M enterprise value, roughly 90x sales, by a sponsor team whose last three completed de-SPACs are down between 95% and 99.9%. The customer and pipeline claims that anchor the marketing don't even appear in the legal filing. FY25 revenue was $7.0M (up from $1.3M, so real growth off a tiny base), with a $7.7M net loss and an $18.5M accumulated deficit as of December 2025. The company had $1.0M in cash against $24.8M of current liabilities, and the auditor issued a going-concern qualification, the filing itself states management's plans "cannot be considered probable" of resolving the doubt. The weighted-average remaining customer contract term has fallen from 8.7 to 4.2 to 2.6 months, the opposite of the "long-dated recurring revenue" being marketed. That marketing is the next problem. The press releases and investor deck lead with a "$300M+ qualified recurring pipeline" and a blue-chip logo wall (MIT, NVIDIA/Lepton, Near Protocol). In the 852-page S-4, "300 million" appears zero times, same for "MIT". The claims that sell the deal live only in furnished marketing materials, which carry far less legal liability than the registration statement. When a claim survives in the hype deck but not the filed prospectus, that tells you something. Think it couldnt get worse? Think again. David Boral, BCAR Chairman and CEO is also CEO of D. Boral Capital which is the underwriter. Sponsor, promoter, and underwriter are the same economic interest. And the teams prior completed deals speak for themselves: EF Hutton --> ECD Auto Design (ECDA), Borals own deal, saw ~98% redemptions and now trades at $0.01 after two reverse splits just to stay listed. Northern Lights --> SHF Holdings (SHFS) had 98.9% redemptions and is down ~99% from its post-merger peak. Edoc --> Australian Oilseeds (COOT) had ~98% redemptions, peaked weeks before the merger even closed, and is down ~95%. Three for three, down 95-99.9%. That's the base rate you're betting against. This has every hallmark of a structure built to monetize a hot narrative for sponsor and insider benefit while leaving public holders exposed to a near-certain post-close grind, on the evidence of the same team's prior outcomes. I'm not making a legal accusation about anyone, and I don't need to in order to reach a verdict. The base rate is brutal, the valuation is detached from the financials, and the deal's best claims aren't in the legal document. Avoid and watch for the first XLAB reverse split as confirmation.
·6.5.This is going to skyrocket soon. I'm guessing 30$ before summer. The risk here is low, locked in at around 10$ until the deal is done.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Ei uutisia tällä hetkellä
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Uutiset
Ei uutisia tällä hetkellä
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- 2.6. · MuokattuD. Boral ARC / Exascale Labs (future XLAB). I went through the 852-page S-4 (filed 2026-05-14), AI-assisted, and checked the sponsor's track record. Verdict: uninvestable. A going-concern AI-compute startup with $7M of revenue is being floated at a $500M pre-money / ~$632M enterprise value, roughly 90x sales, by a sponsor team whose last three completed de-SPACs are down between 95% and 99.9%. The customer and pipeline claims that anchor the marketing don't even appear in the legal filing. FY25 revenue was $7.0M (up from $1.3M, so real growth off a tiny base), with a $7.7M net loss and an $18.5M accumulated deficit as of December 2025. The company had $1.0M in cash against $24.8M of current liabilities, and the auditor issued a going-concern qualification, the filing itself states management's plans "cannot be considered probable" of resolving the doubt. The weighted-average remaining customer contract term has fallen from 8.7 to 4.2 to 2.6 months, the opposite of the "long-dated recurring revenue" being marketed. That marketing is the next problem. The press releases and investor deck lead with a "$300M+ qualified recurring pipeline" and a blue-chip logo wall (MIT, NVIDIA/Lepton, Near Protocol). In the 852-page S-4, "300 million" appears zero times, same for "MIT". The claims that sell the deal live only in furnished marketing materials, which carry far less legal liability than the registration statement. When a claim survives in the hype deck but not the filed prospectus, that tells you something. Think it couldnt get worse? Think again. David Boral, BCAR Chairman and CEO is also CEO of D. Boral Capital which is the underwriter. Sponsor, promoter, and underwriter are the same economic interest. And the teams prior completed deals speak for themselves: EF Hutton --> ECD Auto Design (ECDA), Borals own deal, saw ~98% redemptions and now trades at $0.01 after two reverse splits just to stay listed. Northern Lights --> SHF Holdings (SHFS) had 98.9% redemptions and is down ~99% from its post-merger peak. Edoc --> Australian Oilseeds (COOT) had ~98% redemptions, peaked weeks before the merger even closed, and is down ~95%. Three for three, down 95-99.9%. That's the base rate you're betting against. This has every hallmark of a structure built to monetize a hot narrative for sponsor and insider benefit while leaving public holders exposed to a near-certain post-close grind, on the evidence of the same team's prior outcomes. I'm not making a legal accusation about anyone, and I don't need to in order to reach a verdict. The base rate is brutal, the valuation is detached from the financials, and the deal's best claims aren't in the legal document. Avoid and watch for the first XLAB reverse split as confirmation.
- ·6.5.This is going to skyrocket soon. I'm guessing 30$ before summer. The risk here is low, locked in at around 10$ until the deal is done.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
Sijoittajakalenteri ei ole saatavilla | ||
Uutiset
Ei uutisia tällä hetkellä
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
| Seuraava tapahtuma | |
|---|---|
Sijoittajakalenteri ei ole saatavilla | |
| Menneet tapahtumat | ||
|---|---|---|
Sijoittajakalenteri ei ole saatavilla | ||
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- 2.6. · MuokattuD. Boral ARC / Exascale Labs (future XLAB). I went through the 852-page S-4 (filed 2026-05-14), AI-assisted, and checked the sponsor's track record. Verdict: uninvestable. A going-concern AI-compute startup with $7M of revenue is being floated at a $500M pre-money / ~$632M enterprise value, roughly 90x sales, by a sponsor team whose last three completed de-SPACs are down between 95% and 99.9%. The customer and pipeline claims that anchor the marketing don't even appear in the legal filing. FY25 revenue was $7.0M (up from $1.3M, so real growth off a tiny base), with a $7.7M net loss and an $18.5M accumulated deficit as of December 2025. The company had $1.0M in cash against $24.8M of current liabilities, and the auditor issued a going-concern qualification, the filing itself states management's plans "cannot be considered probable" of resolving the doubt. The weighted-average remaining customer contract term has fallen from 8.7 to 4.2 to 2.6 months, the opposite of the "long-dated recurring revenue" being marketed. That marketing is the next problem. The press releases and investor deck lead with a "$300M+ qualified recurring pipeline" and a blue-chip logo wall (MIT, NVIDIA/Lepton, Near Protocol). In the 852-page S-4, "300 million" appears zero times, same for "MIT". The claims that sell the deal live only in furnished marketing materials, which carry far less legal liability than the registration statement. When a claim survives in the hype deck but not the filed prospectus, that tells you something. Think it couldnt get worse? Think again. David Boral, BCAR Chairman and CEO is also CEO of D. Boral Capital which is the underwriter. Sponsor, promoter, and underwriter are the same economic interest. And the teams prior completed deals speak for themselves: EF Hutton --> ECD Auto Design (ECDA), Borals own deal, saw ~98% redemptions and now trades at $0.01 after two reverse splits just to stay listed. Northern Lights --> SHF Holdings (SHFS) had 98.9% redemptions and is down ~99% from its post-merger peak. Edoc --> Australian Oilseeds (COOT) had ~98% redemptions, peaked weeks before the merger even closed, and is down ~95%. Three for three, down 95-99.9%. That's the base rate you're betting against. This has every hallmark of a structure built to monetize a hot narrative for sponsor and insider benefit while leaving public holders exposed to a near-certain post-close grind, on the evidence of the same team's prior outcomes. I'm not making a legal accusation about anyone, and I don't need to in order to reach a verdict. The base rate is brutal, the valuation is detached from the financials, and the deal's best claims aren't in the legal document. Avoid and watch for the first XLAB reverse split as confirmation.
- ·6.5.This is going to skyrocket soon. I'm guessing 30$ before summer. The risk here is low, locked in at around 10$ until the deal is done.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt